Feb 13, 2020 DVM Practical Approach to Immune-Mediated Hemolytic Anemia 

Immune-mediated hemolytic anemia (IMHA) is a life-threatening red blood cell disorder. Thorough diagnostic investigation is necessary to ensure an accurate diagnosis is made. Multimodal therapeutic interventions, including immunomodulatory therapy and thromboprophylaxis, are indicated to maximize the likelihood of a positive outcome.

RACE approval for DVMs only.